{"id":14542,"date":"2020-09-10T13:46:47","date_gmt":"2020-09-10T11:46:47","guid":{"rendered":"https:\/\/idibell.cat\/es\/?p=14542"},"modified":"2020-09-10T13:47:58","modified_gmt":"2020-09-10T11:47:58","slug":"el-grupo-de-investigacion-en-sarcoma-del-idibell-recibira-una-de-las-nuevas-ayudas-aecc-innova","status":"publish","type":"post","link":"https:\/\/idibell.cat\/es\/2020\/09\/el-grupo-de-investigacion-en-sarcoma-del-idibell-recibira-una-de-las-nuevas-ayudas-aecc-innova\/","title":{"rendered":"El grupo de investigaci\u00f3n en sarcoma del IDIBELL recibir\u00e1 una de las nuevas ayudas AECC Innova"},"content":{"rendered":"<p>La Asociaci\u00f3n Espa\u00f1ola Contra el C\u00e1ncer (<a href=\"https:\/\/www.aecc.es\/es\">AECC<\/a>) ha seleccionado el proyecto del <strong>Dr. \u00d3scar Mart\u00ednez-Tirado<\/strong>, jefe del grupo de investigaci\u00f3n en sarcoma del Instituto de Investigaci\u00f3n Biom\u00e9dica de Bellvitge (<a href=\"https:\/\/idibell.cat\/es\/investigacion\/area-de-cancer\/programa-de-mecanismos-moleculares-y-terapia-experimental-en-oncologia-oncobell\/sarcoma\/\">IDIBELL<\/a>), para recibir una de sus nuevas ayudas \u201c<strong>AECC Innova<\/strong>\u201d. Estas ayudas pretenden apoyar a los grupos de investigaci\u00f3n en la transferencia de los resultados del laboratorio al mercado. Por el momento la AECC ha dotado con 180.000 euros para dos a\u00f1os a tres de los proyectos de investigaci\u00f3n m\u00e1s ambiciosos y con mayor potencial, entre los que se encuentra el proyecto del Dr. Mart\u00ednez-Tirado.<\/p>\n<p>&nbsp;<\/p>\n<h3>Una nueva v\u00eda terap\u00e9utica para el sarcoma de Ewing<\/h3>\n<p>&nbsp;<\/p>\n<p>El sarcoma de Ewing es un tumor \u00f3seo muy agresivo que afecta principalmente a ni\u00f1os y adolescentes. Este tipo de c\u00e1ncer se sigue tratando igual que hace m\u00e1s de 20 a\u00f1os, utilizando tratamientos muy agresivos, que producen graves efectos secundarios, y solo consiguen salvar a 6 de cada 10 pacientes. Ahora, la ayuda AECC Innova permitir\u00e1 al Dr. \u00d2scar Mart\u00ednez-Tirado desarrollar una nueva v\u00eda terap\u00e9utica para este tipo de tumor.<\/p>\n<p>El equipo del Dr. Mart\u00ednez-Tirado validar\u00e1 para su uso cl\u00ednico unas <strong>nanopart\u00edculas<\/strong>, previamente estudiadas en su laboratorio con resultados prometedores, que funcionan como peque\u00f1os drones, capaces de viajar por el cuerpo del paciente hasta llegar a las c\u00e9lulas cancer\u00edgenas y eliminarlas de manera selectiva.<\/p>\n<p>Esta aproximaci\u00f3n podr\u00eda abrir la puerta a un <strong>tratamiento personalizado<\/strong> m\u00e1s eficaz y seguro para pacientes con sarcoma de Ewing.\u00a0Adem\u00e1s, esta tecnolog\u00eda podr\u00eda adaptarse para utilizarse en el tratamiento de otros tipos de tumores.<\/p>\n<p><em>\u201cNuestro proyecto est\u00e1 en un momento cr\u00edtico para dar el salto a la tan ansiada pr\u00e1ctica cl\u00ednica. Trat\u00e1ndose de un sarcoma pedi\u00e1trico el tema es de extraordinaria sensibilidad. Gracias a esta nueva modalidad de ayudas (Innova) de la AECC, nuestro proyecto recibir\u00e1 el empuje necesario para iniciar un proceso tan complejo como la puesta a punto de un ensayo cl\u00ednico\u201d<\/em>, asegura \u00d2scar Mart\u00ednez-Tirado.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>El grupo liderado por el Dr. \u00d3scar Mart\u00ednez-Tirado recibir\u00e1 180.000 euros en dos a\u00f1os para desarrollar una nueva terapia para el sarcoma de Ewing.<\/p>\n","protected":false},"author":8,"featured_media":14543,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[184,281,241],"tags":[],"class_list":["post-14542","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-area-cancer","category-programa-de-mecanismos-moleculares-y-terapia-experimental-en-oncologia-oncobell","category-sarcoma"],"publishpress_future_action":{"enabled":false,"date":"2025-05-01 23:04:59","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category"},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/posts\/14542","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/comments?post=14542"}],"version-history":[{"count":0,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/posts\/14542\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/media\/14543"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/media?parent=14542"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/categories?post=14542"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/tags?post=14542"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}